News Sentiment

ONCIN sentiment intelligence

Oncoinvent ASA news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 6 relevant articles
Exchange OSL Norway
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 49.00 Week of 19 Jun 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 6

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+11.9% over one week, +6.5% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Oncoinvent reaches halfway point in ovarian cancer trial enrollment By Investing.com

Market Reaction

Price moving ahead of tone

58/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 79/100 classification
One-week reaction 11.9% Price confirming higher
Trend fit Trend inactive 6.5% over four weeks
Fair value -90.8% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 6
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 6
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 2
Investing.com UK 1
Finansavisen 1
BeBeez International 1
BioSpace 1

Event Lens

What the news is about

Classified themes
Market update 5
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-6 of 6